Search results
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 2 days agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 7 days agoIf everything goes as planned, the company will produce at least eight new blockbuster medicines...
BioNTech gets $145 million funding for African vaccine plants
WSAU Wausau· 7 days agoBy Ludwig Burger FRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days ago-labeled treatment courses from the U.S. government. Newly acquired product Nurtec ODT/Vydura...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Scientists are testing mRNA vaccines to protect cows and people against bird flu
Seattle Times· 5 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...